Across TCGA pan-cancer cohorts, MPEG1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated MPEG1 data layer compared with 23 for mass-spec protein and 4 for mass-spec protein.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MPEG1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated MPEG1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCEC show a favorable association.
BLCA, DLBC, and LIHC are the cancer types where MPEG1 Mutation most reproducibly stratifies survival.